Skip to main content
Annals of Saudi Medicine logoLink to Annals of Saudi Medicine
. 2006 Mar-Apr;26(2):147–149. doi: 10.5144/0256-4947.2006.147

Endocarditis caused by Pasteurella multocida

Mohammed A Al Ghonaim *,, Abdullah A Abba , Mansour Al Nozha
PMCID: PMC6074155  PMID: 16761455

Pasturella multocida, a small gram-negative coccobacillus, is primarily a pathogen in animals, but can cause a variety of infections in humans.1 Infection usually follows a bite or contact with secretions from felines such as dogs or cats. Infection is usually followed by cellulitis, but the organism has been implicated in pneumonia, meningitis, liver abscess and osteomyelitis. Systemic infection is rare; only eleven cases of P. multicoda endocarditis have been reported in the English literature. We report a case of P. multocida endocarditis in a Saudi patient who had frequent contact with sheep, but in whom there was no clear portal of entry of the organism. In addition, the patient had no co-morbid conditions and was not immunosuppressed. To our knowledge, this is the twelfth reported case of endocarditis by this unusual organism in the English literature. We review the previously reported eleven cases.

Case

A 50-year-old Saudi presented with a 3-week history of dyspnea, orthopnea, proxysmal nocturnal dyspnea, cough and scanty white sputum. There was no fever or other constitutional features, or other symptoms referable to other systems. The patient was a truck driver and had frequent contact with sheep, but could not recollect a bite or a skin lesion prior to presentation. He had no significant current or past medical history.

On physical examination, he was in respiratory distress with the following vital signs: respiratory rate of 23/min, pulse rate 100/min, blood pressure 120/60 mm Hg and a temperature of 38.9°C. He had splinter haemorrhages but no other peripheral signs of endocarditis. He was in sinus rhythm and the pulse was collapsing in character. The jugular venous pressure was elevated at 4 cm and he had signs of mitral and aortic regurgitation. Examination of the respiratory system revealed bilateral basal inspiratory crepitations. Examination of the abdomen, fundi and the central nervous system was unremarkable. There were no obvious skin lesions to suggest a recent or remote animal bite. He was not on any medications.

Investigations revealed mild leucocytosis at 12.0 x 103/μL, normal haemoglobin, and normal renal and hepatic function. A chest radiograph showed cardiomegaly with pulmonary oedema and the electrocardiogram showed sinus rhythm, left axis deviation and left ventricular hypertrophy. An echocardiogram showed dilated left ventricle and atrium. A large vegetation, noted at the non-coronary cusp, was freely moving in the left ventricular outflow tract. There was severe aortic regurgitation with aortic root abscess and mild mitral regurgitation. Blood culture grew P. multocida on four occasions. The organism was oxidase, catalase and indole positive and identification was confirmed by using API 20E (Bio Merieux, France). Screening was negative for the human immunodeficiency virus (HIV).

The patient was treated with penicillin, gentamicin and anti-failure measures. He underwent aortic valve replacement after four days of medical treatment. The histology of the diseased valve confirmed endocarditis although the culture was negative. He made an uneventful recovery and remains well after a two-year follow up.

Discussion

The case satisfied Duke’s criteria for the diagnosis of endocarditis in having two of the major criteria and one minor criterion. Although P. multocida can be easily misidentified, the methods we used distinguished it from organisms such as Haemophilus aphrophilus and Haemophilus parainfluenzae. To our knowledge, this is the twelfth reported case of P. multocida endocarditis in the English literature.212 Table 1 gives the details of the previously reported cases.

Table 1.

Endocarditis due to P. multocida: summary of cases described in English medical literature.

Case No. Year of Publication Age (year) & Sex Animal Exposure Valvular vegetation Co-morbid condition Outcome
1 19702 10 / F No NR NR Recovered but died soon of uncertain cause
2 19773 51 / M - AV NR Survived, required AVR
3 19834 50 / M Dog /sheep NR NR Died
4 19895 63 / F Dog AV Glomerulonephritis Recovered, required AVR*
5 19906 17 / M No MV Renal insufficiency Died of intra cerebral hemorrhage
6 19927 61 / M Dog AV Polycystic kidneys Died*
7 19968 72 / F Cat AV Prosthesis Liver cirrhosis Survived
8 19979 65 / M Dog AV Prosthetic valve Died*
9 199810 65 / M Dog NR Liver cirrhosis Died
10 200211 48 / M Dog MV Pre-existing MV stenosis Survived. Required MVR
11 200312 48 / F Dog AV Liver cirrhosis Survived, recurrent endocairditis after AVR
12 2005 (PR) 50 / M Sheep AV No known co-morbid condition Survived, required AVR

F=Female, M=Male, NR=No record, AV=Aortic valve, MV=Mitral valve, AVR=Aortic valve replacement, MVR=Mitral valve replacement, AVR = Aortic valve replacement, PR =Present report.

The organism is usually recovered from the nasopharnynx or gastrointestinal tract of felines and is a component of oral flora in most mammals. Infection in man follows animal bite or contact with secretions. The most common sequel are cellulitis, subcutaneous abscesses, and skin ulcers. Other less commonly affected organs include the bones and joints, and the oral and respiratory tract. Bacteremia is uncommon and endocarditis rarely results from such bacteremia. In a series of thirteen cases with bacteremia, Raffi and his associates13 reported none with endocarditis. Culture of the excised valve in our case did not grow the organism. This is similar to the case reported by Lehmann et al3 and may be the result of the antibiotics the patient received earlier.

Patients with P. multocida infections often have other co-morbid conditions such a chronic obstructive lung disease, bronchiectasis, chronic liver disease or immunosuppression. Our patient had no prior co-morbid state. In addition, he was not on any immunosuppressants nor was he positive for the HIV virus.

The organism is highly susceptible to numerous antibiotics including penicillins, cephalosporins, tetracyclines, and chloramphenicol. Penicillin is the drug of choice.14 Despite susceptibility to, and treatment with these readily available antibiotics, about half of the reported cases of endocarditis died and valve replacement was required in another one third. The outcome is probably related to the duration of illness and the rapidity with which diagnosis is made and treatment commenced. P. multocida is a recognized but rare cause of endocarditis, and although the organism is susceptible to many antibiotics, it can run a fatal cause if not recognized early.

References

  • 1.Weber DJ, Wolfson JS, Swartz MN, Hooper DC. Pasteurella multocida infections: Report of 34 cases and review of literature. Medicine. 1984;63(2):133–154. [PubMed] [Google Scholar]
  • 2.Phillips I, Midgley J, Lapage SP. Endocarditis due to a Pusteurella-like organism. East Afr Med J. 1970;47(8):440–4. [PubMed] [Google Scholar]
  • 3.Lehmann V, Knotsen SB, Ragnhildstveit F, Skagseth E, Solberg C. Endocarditis caused by P. multocida. Scand J Infec Dis. 1977;9:247–8. doi: 10.3109/inf.1977.9.issue-3.19. [DOI] [PubMed] [Google Scholar]
  • 4.Singh CP, Spurrell JR. Pasteurella multocida endocarditis. Br Med J (Clin Res Ed) 1983;286(6381):1862–3. doi: 10.1136/bmj.286.6381.1862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Salmon D, Fantin B, Bricaire F, Vilde JL, Pangon B, Ferand D. Endocarditis due to Pasteurella multocida with glomerulitis. Am J Med. 1989;86(4):493. doi: 10.1016/0002-9343(89)90356-2. [DOI] [PubMed] [Google Scholar]
  • 6.Thamlikitkul V, Sangruchi T. Pasteurella multocida infective endocarditis: a case report. J Med Assoc Thai. 1990;73(12):704–6. [PubMed] [Google Scholar]
  • 7.Hombal SM, Dincsoy HP. Pasteurella multocida endocarditis. Am J Clin Pathol. 1992;98(6):565–8. doi: 10.1093/ajcp/98.6.565. [DOI] [PubMed] [Google Scholar]
  • 8.Genne D, Siegrist HH, Monnier P, Nobel M, Humair L, de Torrente A. Pasteurella multocida endocarditis: report of a case and review of the literature. Scand J Infect Dis. 1996;28(1):95–7. doi: 10.3109/00365549609027158. [DOI] [PubMed] [Google Scholar]
  • 9.Nettles RE, Sexton DJ. Pateurella multocida Prosthetic Valve Endocarditis: Case report and Review. Clin Infect Dis. 1997;25:920–1. doi: 10.1086/597637. [DOI] [PubMed] [Google Scholar]
  • 10.Vasquez JE, Ferguson DA, Bin-Sagheer S, Myers JW, Ramsak A, Wilson MA, Sarubbi FA. Pasteurella multocida Endocarditis: A molecular epidemiological study. Clin Infect Dis. 1998;26:518–20. doi: 10.1086/517105. [DOI] [PubMed] [Google Scholar]
  • 11.Fukumoto Y, Moriyama Y, Iguro Y, Toda R, Taira A. Pasteurella multocida: report of a case. Surg Today. 2002;32(6):513–5. doi: 10.1007/s005950200087. [DOI] [PubMed] [Google Scholar]
  • 12.Fayad G, Modine T, Mokhtari S, Legout L, Decoene C, Azzaoui R, et al. Pasteuerella multocida aortic valve endocarditis: case report and literature review. J Heart Valve Dis. 2003;12(2):261–3. [PubMed] [Google Scholar]
  • 13.Raffi F, Barrier J, Barou D, Drugeon H, Nicolas F. Pusteurella multocida bacteremia: Report of thirteen cases over twelve years and review of the literature. Scand J Infec Dis. 1987;19:385–393. doi: 10.3109/00365548709021670. [DOI] [PubMed] [Google Scholar]
  • 14.Mortensen JE, Giger D, Rodgers GL. In vitro activity of oral anti microbial agents against clinical isolates of Pasteurella multocida. Diagn Microbiol Infect Dis. 1998;30:99. doi: 10.1016/s0732-8893(97)00209-5. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Saudi Medicine are provided here courtesy of King Faisal Specialist Hospital and Research Centre

RESOURCES